2006, Number 10
<< Back Next >>
Ginecol Obstet Mex 2006; 74 (10)
Medical attitude regarding the negative of receiving blood transfusions by Jehovah's Witness patients
Tena TC, Sánchez GJM, Campos CEM
Language: Spanish
References: 37
Page: 523-531
PDF size: 298.48 Kb.
ABSTRACT
Background: Hemoderivative and blood transfusions without proper medical indication bring uncertain benefits, increase health risks and adverse effects. It is necessary to also consider the patient’s values and preferences and the denial to receive transfusions. A deficient medical evaluation and an unnecessary transfusion can generate untoward effects regarding patients’ health and safety.
Material and methods: A retrospective, observational, and transverse study of 767 complaints for alleged denial of medical attention presented by Jehovah’s Witness patients was undertaken, coupled with their denial to receive blood transfusions and their perception of the problem.
Results: It was established that 95.6% of cases studied involved adult patients, while 4.4% involved underage patients, with a mean of 43 years. The majority of complaints appeared at the secondary level of medical attention, 64.5% came from social security institutions and 19% from private institutions. The motive for medical consultation was surgical in 91.9% cases. 98.7% of the complaints were due to a perceived denial of medical attention, associated to religious conviction. 1.3% of complaints were filed after having received blood transfusions, without proper patient consent. The major health problems were solved in different medical units from the beginning in 500 cases (65.2%). Medical care was provided in 450 cases, in private clinics, while 50 cases were cared for in public institutions without the need for transfusion.
Conclusions: Several studies coincide on the high number of unnecessary or unjustified blood transfusions. To improve the quality of transfusion medicine steps should be taken to install specialized hospital committees, update the use of guidelines based on the best scientific evidence, as well as to respect patient autonomy.
REFERENCES
Izaguirre-Avila R, Micheli A. En torno a la historia de las transfusiones sanguíneas. Rev Invest Clin 2002;54(6):552-8.
Starr D. Historia de la sangre, leyendas, ciencia y negocio. Barcelona: Ediciones B, 2000;pp:320-530.
Córdova MS, et al. Medicina transfusional. Transfusión 1991;31(270):78-81.
AuBuchon JP, Birkmeyer JD, Busch MP. Safety of the blood supply in the United States: opportunities and controversies. Ann Inter Med 1997;127(2):904-9.
Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003;289(8):959-62.
Corbalá-Fuentes C, Navarro-Jaramillo F, Aguilar-Solano A, et al. Análisis del uso clínico de la hemotransfusión. Rev Mex Pat Clin 2003;50:104-8.
Barrlet R. Current concepts and clinical strategies in blood less medicine and surgery. En: Culotta E. The new standard of care workshop. Washington, DC: AABB, 2000.
Tuckfield A, Haeusler M, Grigg A, et al. Reduction of inapprpiate use of blood products by prospective monitoring of transfusion request forms. Med J Aust 1997;167:473-6.
Practice guidelines for blood component theraphy. A report by American Society of Anesthesiologistists. Task force on blood component therapy. Anesthesiology 1996;84:732-47.
García J, Rodríguez P, Bernal T, et al. Adecuación de la transfusión de hemoderivados a criterios previamente establecidos. Sangre 1996;41(1):19-23.
Pita L, Cabrera B, Ortega C. Motivos de transfusión de plasma fresco congelado en un hospital general. Rev Invest Clin 1999;51:89-92.
Juárez-Rangel E, Vite-Casanova MJ, Marín y López R, Sánchez-Guerrero SA. Auditoría transfusional retrospectiva en el Centro Nacional de la Transfusión Sanguínea. Rev Invest Clin 2004;56(1):38-42.
British comitee for Standard in hematology, blood transfusion task force in collaboration with the Royal Collage of Nursing and the Royal Collage of Surgenos of England. The administration of blood components and the management of transfused patients. Trans Med 1999;9:227-38.
Ramírez-Salazar C, Jiménez-Corona ME, Rivera Cisneros AE. Aspectos jurídicos en casos de transfusión sanguínea en Testigos de Jehová. Gac Med Mex 2003;139(4):423-6.
Pimentel-Pérez AG. Los testigos de Jehová y el consentimiento informado. Rev Med IMSS 2002;40:495-504.
Aldana-Valenzuela C. Aspectos éticos en medicina perinatal: el paciente testigo de Jehová. Med y Ética 2001:35-40.
Pérez F, Gredilla EV, García F, Reinoso B. Fundamentos del rechazo a la transfusión sanguínea por los Testigos de Jehová. Aspectos ético-legales y consideraciones anestésicas en su tratamiento. Rev Esp Anestesiol Reanim 2006;53(1):31-41.
Norma Oficial Mexicana NOM-003-SSA2-1993 “Para la disposición de sangre humana y sus componentes con fines terapéuticos”.
Garay A. Libertad de conciencia y tratamiento médico: el caso del consentimiento a la transfusión sanguínea. Rev Latinoam Der Medic Leg 2000;5(1):11-15.
Casamadrid Mata OR. Aspectos Conceptuales; la atención médica y la legislación sanitaria. En: La atención médica y el derecho sanitario. México: Editorial JHG, 1999;pp:5-6, 25-27.
Riley DT. Jewhovah’s Witnesses refusal of blood, obeddience to scripture and religion conscience. J Med Ethics 1999;25:469-72.
Muramoto O. Medical confidentiality and the protection of Jehovah’s Witnesses ormolus refusal of blood. J Med Ethics 2000;26:381-6.
Rodríguez Moyado H. Medicina sin transfusiones. Rev Med IMSSS 2005;43(3):229-35.
Constitución Política de los Estados Unidos Mexicanos.
Ley General de Salud. Leyes y Códigos de México. México: Porrua, 2000.
Ley reglamentaria del artículo 5° constitucional relativo al ejercicio profesional
Código Civil Federal México, D.F., 2004.
Cardemi-Herrera G. Alternativas al uso de sangre y derivados. Sociedad Chilena de Medicina Interna. Hospital Clínico Universidad de Chile 2003:17-28.
Barba-Evia J. Transfusión de sangre y sus componentes. Rev Mex Patol Clin 2004;51:97-118.
American College of Physicians. Clinical guideline. Practice strategies for effective red blood cell transfusion. Ann Intern Med 1992;116(5):403-6.
Recomendaciones para la terapia transfusional de sangre y sus componentes, 2° Consenso Nacional de Expertos en Medicina Transfusional. Asociación Mexicana de Medicina Transfusional, A.C., Comité de Medicina Transfusional de la Agrupación Mexicana de Hematología, A.C. San Juan del Río, Qro. México 2003. Malagón-Martínez A, Berges-García AS, Bravo-Lindoro A, et al. Recomendaciones para la terapia transfusional “Consenso Nacional de Expertos en Medicina Transfusional. Mineral del Chico, Hidalgo y San Juan del Río Querétaro” Gac Med Méx 2003;139Supl3:44-73.
Gutiérrez Gómez C. Autotransfusión. Cir Plast 2004;14(1):40-43.
Abad-Hernández RM, Rey Martínez B, Avela-Lazo A, Pérez -Martínez G. Criterios médicos anestesiólogos de la ciudad de La Habana sobre el hematocrito perioperatorio y la indicación de glóbulos. Rev Cubana Cir 2001;40:24-28.
Fernández Suárez LM, Monjiotti Z. Hemodilución normovolémica intencional alternativa práctica para la transfusión homóloga de sangre en cirugía general y especializada. Rev Cubana Cir 2000;39:152-9.
Goodnough TL. The use of eritropoietin to increase red cell mass. Can J Anesth 2003;50:10-18.
Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005;95(1):33-42. doi:10.1093/bja/ aeh290.
Tena Tamayo C, Sánchez González JM. La transfusión sanguínea y los derechos del paciente. Rev CONAMED 2005;10(2):20-26.